Titre :
  • Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.
Auteur : Eggermont, A ; Suciu, Stefan ; Testori, Alessandro ; Santinami, M. ; Kruit, Wim H ; Marsden, Jeremy ; Punt, Cornelis ; Sales, François ; Dummer, Reinhard ; Robert, Caroline ; Schadendorf, Dirk ; Patel, Poulam ; de Schaetzen, Gaetan ; Spatz, Alain ; Keilholz, Ulrich
Informations sur la publication : Journal of clinical oncology, 30, 31, (page 3810-3818)
Statut de publication : Publié, 2012-11
Sujet CREF : Cancérologie
Mots-clés MeSH : Adolescent
Adult
Aged
Chemotherapy, Adjuvant
Follow-Up Studies
Humans
Interferon-alpha -- therapeutic use
Melanoma -- drug therapy -- pathology -- surgery
Middle Aged
Neoplasm Staging
Polyethylene Glycols -- therapeutic use
Recombinant Proteins -- therapeutic use
Skin Neoplasms -- drug therapy -- pathology -- surgery
Young Adult
Note : Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2011.41.3799
info:pii/JCO.2011.41.3799
info:pmid/23008300